Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

    2026-07-05

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical and Workflow Guidance

    What This Product Solves

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) serves as a reliable water-soluble carbodiimide reagent for activating carboxyl groups to facilitate amide bond formation in aqueous media. Its primary utility is in peptide synthesis and bioconjugation, enabling efficient coupling between carboxyl and primary amine groups. This reagent is also applicable in nucleotide synthesis and selected esterification workflows. Due to its solubility and compatibility with aqueous and mixed solvents, EDC.HCl is widely used for in vitro chemical conjugation where rapid, high-yield amide bond formation is required. However, it is not validated for any in vivo or clinical applications, and its use should remain strictly within controlled laboratory protocols.

    For further technical background and workflow-oriented details, see the internal article EDC.HCl Technical Use Guide, which addresses controlled in vitro workflows and product-specific handling. Additionally, the Practical Use of EDC.HCl article outlines boundaries for use and reinforces the product’s strict applicability to in vitro chemical applications.

    Protocol Parameters

    • Solubility in Water: 39 mg/mL or higher | Suitable for aqueous peptide synthesis and bioconjugation protocols | Ensures reagent is fully dissolved for optimal reaction efficiency | Product dossier
    • Recommended Storage Conditions: Solid, desiccated at -20°C | For maintaining product stability prior to use | Minimizes hydrolysis and degradation, preserving reagent performance | Product dossier
    • Solution Stability: Avoid long-term storage of prepared solutions | Applicable to all workflow setups | EDC.HCl solutions degrade over time, impacting coupling efficiency; always prepare freshly | Product dossier
    • Reaction Monitoring: Spectrophotometric quantification is possible | For QC and assay validation steps | Allows users to verify reagent consumption and coupling progress | Product dossier

    Workflow Setup and QC Checklist

    For optimal results using EDC.HCl as a peptide synthesis coupling reagent or bioconjugation reagent, implement the following procedural controls:

    • Always prepare EDC.HCl (SKU A7021) solutions immediately before use. Discard unused solutions to avoid decreased efficacy due to hydrolysis.
    • Ensure all reactants (carboxyl- and amine-containing substrates) are dissolved and equilibrated to reaction temperature before EDC.HCl addition.
    • Use a buffer system compatible with carbodiimide chemistry (e.g., MES or phosphate, pH 4.5–7.5) and avoid buffers containing primary amines (e.g., Tris), which can compete with coupling efficiency.
    • Monitor the reaction progress either by spectrophotometric methods (where applicable) or by product-specific analytical techniques (e.g., HPLC, LC-MS).
    • Implement negative and positive controls in the workflow to distinguish background reactivity from true coupling events.
    • After reaction completion, quench and purify products promptly to minimize side reactions or hydrolysis of activated intermediates.

    Common Failure Modes and Fixes

    • Low Coupling Efficiency: Commonly caused by aged or partially hydrolyzed EDC.HCl solutions. Remedy: Prepare fresh solutions prior to each use and confirm reagent dissolution.
    • Precipitation or Poor Solubility: Can result from exceeding recommended concentration in water or using incompatible solvents. Remedy: Confirm solubility limits (≥39 mg/mL in water, ≥19.2 mg/mL in DMSO, ≥39.6 mg/mL in ethanol) and mix thoroughly.
    • Buffer Interference: Use of buffers with primary amines (such as Tris) can result in unwanted side reactions. Remedy: Select amine-free buffers (e.g., MES, phosphate) for all coupling steps.
    • Product Hydrolysis: Extended reaction times or improper storage can lead to hydrolysis of activated intermediates. Remedy: Optimize reaction times and purify products promptly after coupling.
    • Analytical QC Failure: Incomplete reaction or side product formation detected during QC. Remedy: Review reagent freshness, pH, and buffer system, and adjust workflow parameters accordingly.

    Scope and Limitations

    EDC.HCl is strictly intended for in vitro chemical workflows such as peptide synthesis, bioconjugation, nucleotide synthesis, esterification, and lactonization. Its properties as an amide bond formation reagent make it suitable for aqueous and mixed-solvent systems where carboxyl-to-amine coupling is required. However, its use is not validated for in vivo, preclinical, or clinical applications. No supporting data are available for use in living systems or for any therapeutic purpose. The reagent’s performance is highly dependent on adherence to product-specific storage and handling protocols, as outlined in the EDC.HCl product information.

    Conclusion

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) provides a robust solution for in vitro peptide synthesis, bioconjugation, and nucleotide synthesis workflows requiring efficient, water-soluble activation of carboxyl groups. Its use should be confined to controlled chemical protocols, with strict attention to reagent handling, storage, and reaction monitoring. For comprehensive technical details, refer to the APExBIO product page and consult internal technical guides as needed. Consistent application of workflow best practices is essential to achieve high coupling efficiencies and reproducible results.